作者
L Sun, RJ Clarke, DA Bennett, Y Guo, RG Walters, MR Hill, S Parish, IY Millwood, Z Bian, Y Chen, C Yu, J Lv, R Collins, J Chen, R Peto, L Li, Z Chen
发表日期
2019
期刊
Nature Medicine
卷号
25
页码范围
569-574
简介
Stroke is the second leading cause of death worldwide and accounts for >2 million deaths annually in China,. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) account for an equal number of deaths in China, despite a fourfold greater incidence of IS,. Stroke incidence and ICH proportion are higher in China than in Western populations, –, despite having a lower mean low-density lipoprotein cholesterol (LDL-C) concentration. Observational studies reported weaker positive associations of LDL-C with IS than with coronary heart disease (CHD),, but LDL-C-lowering trials demonstrated similar risk reductions for IS and CHD, –. Mendelian randomization studies of LDL-C and IS have reported conflicting results, –, and concerns about the excess risks of ICH associated with lowering LDL-C, may have prevented the more widespread use of statins in China. We examined the associations of biochemically …
引用总数
20182019202020212022202320241144448564233